These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 26444005

  • 1. Functional characterization of biodegradable nanoparticles as antigen delivery system.
    Petrizzo A, Conte C, Tagliamonte M, Napolitano M, Bifulco K, Carriero V, De Stradis A, Tornesello ML, Buonaguro FM, Quaglia F, Buonaguro L.
    J Exp Clin Cancer Res; 2015 Oct 06; 34():114. PubMed ID: 26444005
    [Abstract] [Full Text] [Related]

  • 2. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.
    Song C, Noh YW, Lim YT.
    Int J Nanomedicine; 2016 Oct 06; 11():3753-64. PubMed ID: 27540289
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M, Lin MY, Bal SM, van Meijgaarden KE, Franken KL, Friggen AH, Junginger HE, Borchard G, Klein MR, Ottenhoff TH.
    Vaccine; 2009 Jun 19; 27(30):4010-7. PubMed ID: 19389445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.
    Han HD, Byeon Y, Kang TH, Jung ID, Lee JW, Shin BC, Lee YJ, Sood AK, Park YM.
    Int J Nanomedicine; 2016 Jun 19; 11():5729-5742. PubMed ID: 27843314
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S, Russo A, Pagliara V, Conte C, Ungaro F, Russo G, Quaglia F.
    J Nanobiotechnology; 2015 Apr 03; 13():29. PubMed ID: 25888948
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
    Han R, Zhu J, Yang X, Xu H.
    J Biomed Mater Res A; 2011 Jan 03; 96(1):142-9. PubMed ID: 21105162
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of poly(D,L-lactide-co-glycolide) microparticles with polyelectrolyte self-assembled multilayer surfaces on the cross-presentation of exogenous antigens.
    Yang YW, Hsu PY.
    Biomaterials; 2008 Jun 03; 29(16):2516-26. PubMed ID: 18329708
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
    Mittal A, Raber AS, Schaefer UF, Weissmann S, Ebensen T, Schulze K, Guzmán CA, Lehr CM, Hansen S.
    Vaccine; 2013 Jul 25; 31(34):3442-51. PubMed ID: 23290836
    [Abstract] [Full Text] [Related]

  • 16. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
    Shen H, Ackerman AL, Cody V, Giodini A, Hinson ER, Cresswell P, Edelson RL, Saltzman WM, Hanlon DJ.
    Immunology; 2006 Jan 25; 117(1):78-88. PubMed ID: 16423043
    [Abstract] [Full Text] [Related]

  • 17. Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery.
    Zhang Z, Tongchusak S, Mizukami Y, Kang YJ, Ioji T, Touma M, Reinhold B, Keskin DB, Reinherz EL, Sasada T.
    Biomaterials; 2011 May 25; 32(14):3666-78. PubMed ID: 21345488
    [Abstract] [Full Text] [Related]

  • 18. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A, Gu P, Liu Z, Xu S, Zhang Y, Hu Y, Liu J, Wang D, Huang X.
    Int J Nanomedicine; 2019 May 25; 14():3221-3234. PubMed ID: 31123399
    [Abstract] [Full Text] [Related]

  • 19. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses.
    Liu J, Liu X, Han Y, Zhang J, Liu D, Ma G, Li C, Liu L, Kong D.
    ACS Appl Mater Interfaces; 2018 Sep 19; 10(37):30983-30993. PubMed ID: 30136844
    [Abstract] [Full Text] [Related]

  • 20. A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic Cell-Based Cancer Immunotherapy.
    Zhang C, Zhang J, Shi G, Song H, Shi S, Zhang X, Huang P, Wang Z, Wang W, Wang C, Kong D, Li C.
    Mol Pharm; 2017 May 01; 14(5):1760-1770. PubMed ID: 28296410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.